Company Health Advance Inc.

Equities

HADV

US42225L2034

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 19:18:59 31/05/2024 BST			5-day change	1st Jan Change
0.0064 ^USD	-1.92%		-12.33%	-1.54%

2022	Health Advance Inc. Selects Contract Manufacturer for New Treatment Initiative	CI
2018	Health Advance Inc. Announces Executive Changes	CI

Health Advance, Inc. is focused on cannabidiol (CBD) infused dealcoholized wine beverage products and a new nutraceutical product range. Its principal products or services include CBD infused dealcoholized wine and immune boosting nutraceutical in pre-production. The Companyâs subsidiary is Courtship Wines, Inc.

Managers	Title	Age	Since
Larry McLachlin CEO	Chief Executive Officer	-	-

Members of the board	Title	Age	Since
Larry McLachlin CEO	Chief Executive Officer	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	185,947,500	167,632,482 ( 90.15 %)	0	90.15 %

Health Advance, Inc.

9131 Keele Street Suite A4

L4K 0G7, Vaughan

http://healthadvancegroup.com/

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
HEALTH ADVANCE INC.	-1.54%	1.19M
MODERNA, INC.	+43.36%	54.64B
IQVIA HOLDINGS INC.	-5.31%	39.92B
LONZA GROUP AG	+37.52%	38.82B
ICON PUBLIC LIMITED COMPANY	+14.75%	26.86B
CELLTRION, INC.	-12.56%	26.22B
ALNYLAM PHARMACEUTICALS, INC.	-22.45%	18.78B
BIO-TECHNE CORPORATION	+0.04%	12.16B
UNITED THERAPEUTICS CORPORATION	+25.12%	12.21B
MEDPACE HOLDINGS, INC.	+26.04%	11.94B

Other Biotechnology & Medical Research